This year’s two presidential nominees have taken aim at high drug prices — and pharma. A solution may require not just rhetoric but cooperation between industries. When the dust settles after one of the most remarkable presidential campaigns in history, the time for rhetoric will be over and the new president and lawmakers will face the task of actually managing a giant, unwieldy and complex health care system, trying to wrestle drug costs into submission before they wreak even more havoc on the budgets of Medicare, Medicaid, and the American consumer.
http://www.managedcaremag.com/archives/2016/9/both-parties-drug-costs-are-hard-pill-swallow
